vimarsana.com
Home
Live Updates
Singaporean startup FathomX scores almost $2M to hasten breast cancer AI development : vimarsana.com
Singaporean startup FathomX scores almost $2M to hasten breast cancer AI development
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
Related Keywords
Singapore ,
National University Of Singapore ,
Singapore General ,
,
National University Health System ,
National University ,
Diagnostics Development Hub ,
Hewlett Packard Enterprise ,
vimarsana.com © 2020. All Rights Reserved.